#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Deafness bilateral Juvenile psoriatic arthritis Heart disease congenital Neonatal asphyxia Hypochromic anaemia Squamous cell carcinoma of the cervix Malignant glioma Depression Pyruvate dehydrogenase complex deficiency Sarcoma Thromboangiitis obliterans Tuberous sclerosis complex Haemophilia A without inhibitors Amyotrophic lateral sclerosis Cognitive disorder More trials…

    Learn about Rare Diseases

    Acute respiratory distress syndrome – Basic Information Adrenogenital syndrome Glomerulonephritis membranoproliferative – Treatment Amyotrophic lateral sclerosis – Life with Disease Waldenstrom’s macroglobulinaemia refractory – Trials in Disease Angiosarcoma non-metastatic – Treatment Alexander disease – Treatment Bronchiolitis obliterans syndrome – Diagnostics Carcinoid syndrome – Trials in Disease Marfan’s syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Glyceryl Trinitrate Izorlisib Mesilate Elebsiran MEGESTROL ACETATE ALLERGEN EXTRACTS Betula Pollen Extract Mirtazapine Dorzolamide Basimglurant Tetracycline Hydrochloride Setrusumab Mk-1084 Vancomycin Xp-Dc+Tl+Klh Benzalkonium Chloride L-Tryptophan Elamipretide Trihydrochloride Alrefimotide Anb032 Tin816 More therapies…

    Learn about Your Condition

    Melanoma recurrent Deafness traumatic Inclusion body myositis Hairy cell leukaemia Pemphigoid Strongyloidiasis Bronchiolitis Vulvovaginal pain Hepatobiliary cancer Endometrial stromal sarcoma Thrombectomy Small intestine leiomyosarcoma Angelman's syndrome Rectal neoplasm Lysosomal storage disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Prostate cancer recurrent

  • Study on the Safety and Effectiveness of SpectraCure P18 System and Verteporfin for Treating Recurrent Prostate Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer recurrent
    Investigated Drugs:
    • Ciprofloxacin
    Germany Sweden

  • Study Comparing Conventional Radiotherapy and PSMA-PET/CT Targeted Treatment with 18F-PSMA-1007 and Gozetotide for Prostate Cancer Recurrence After Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer recurrent
    Investigated Drugs:
    • Gozetotide
    Sweden

  • Study on Atorvastatin’s Effect on Prostate Cancer Progression in Patients Undergoing Androgen Deprivation Therapy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Prostate cancer recurrent
    • Prostate cancer
    Investigated Drugs:
    • Atorvastatin
    Denmark Estonia Finland Norway

  • Study on the Safety of Lutetium (177Lu) Zadavotide Guraxetan and Radium Ra 223 Dichloride for Patients with Bone-Metastatic Prostate Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer recurrent
    • Prostate cancer
    Investigated Drugs:
    • Lutetium (177Lu) Zadavotide Guraxetan
    • Radium Ra 223 Dichloride
    The Netherlands

  • Study of Pembrolizumab with Radiotherapy for Patients with Recurrent Prostate Cancer After Surgery

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer recurrent
    Investigated Drugs:
    • Pembrolizumab
    Germany

  • Study on Adding Apalutamide to Radiotherapy and LHRH Agonist for High-Risk Patients with Hormone-Sensitive Prostate Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Apalutamide
    Austria Belgium Czechia Denmark Finland Germany +7
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!